Inventor
RIVIER MICHEL
FR22 patents
⚠️ This page may combine multiple inventors who share the name “RIVIER MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALDERMA RES & DEV
16 patentsUS6403656B1Jun 11, 2002
Use of ppar-γ activators in dermatology
GALDERMA RES & DEV51 citations91
US7625914B2Dec 1, 2009
Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV5 citations72
US7307078B2Dec 11, 2007
Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV3 citations62
US7125869B2Oct 24, 2006
Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV4 citations62
US7452878B2Nov 18, 2008
Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV2 citations61
US7285568B2Oct 23, 2007
Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV4 citations61
US7807669B2Oct 5, 2010
Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV0 citations51
US8022079B2Sep 20, 2011
Methods of modulating PPAR gamma-type receptors
GALDERMA RES & DEV0 citations50
US7973063B2Jul 5, 2011
Methods for activating PPAR gamma-type receptors
GALDERMA RES & DEV0 citations50
US7968560B2Jun 28, 2011
Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
GALDERMA RES & DEV0 citations50
US7626054B2Dec 1, 2009
Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV0 citations50
US9889126B2Feb 13, 2018
Use of naratriptan in the treatment of rosacea
GALDERMA RES & DEV0 citations46
US9408793B2Aug 9, 2016
Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositions
GALDERMA RES & DEV0 citations45
US10048279B2Aug 14, 2018
Method for the diagnosis of rosacea
GALDERMA RES & DEV0 citations41
US8383652B2Feb 26, 2013
Biaromatic compounds that modulate PPAR-receptors
GALDERMA RES & DEV0 citations41
US7582663B2Sep 1, 2009
Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
GALDERMA RES & DEV0 citations40
IBM
4 patentsUS6914479B1Jul 5, 2005
Differential amplifier with DC offset cancellation
IBM37 citations90
US7944280B2May 17, 2011
Bandgap reference generator utilizing a current trimming circuit
IBM9 citations84
US5717696AFeb 10, 1998
Circuit for testing a semiconductor chip having embedded arrays intermixed with logic
IBM12 citations73
US6861908B2Mar 1, 2005
2-stage large bandwidth amplifier using diodes in the parallel feedback structure
IBM4 citations60